Maximize your thought leadership

SS Innovations Appoints Sarah Romano as CFO to Support Global Expansion and FDA Approval Efforts

SS Innovations International has appointed Sarah M. Romano as CFO to lead financial operations during its global expansion and pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
SS Innovations Appoints Sarah Romano as CFO to Support Global Expansion and FDA Approval Efforts

SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors. Based in the United States, she will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations.

The appointment comes as SS Innovations seeks to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations aims to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population.

Romano’s experience in raising capital and managing financial operations will be critical as the company pursues FDA approval and expands internationally. The news is significant for investors and the medical technology industry, as it signals SS Innovations’ commitment to strengthening its financial leadership to achieve key milestones. The company’s focus on cost-effective robotic surgery could potentially disrupt the market by making advanced surgical tools more accessible.

For more information, visit the company’s newsroom at https://ibn.fm/SSII and the full press release at https://ibn.fm/pAqlP.

Burstable Editorial Team

Burstable Editorial Team

@burstable

Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.